Elevated mRNA expression of herstatin predicts poor outcome in patients with high-risk early breast cancer. A possible molecular predictor of treatment benefit in the context of a Hellenic cooperative oncology group trial.

2009 ◽  
Author(s):  
CA Papadimitriou ◽  
KT Kalogeras ◽  
RM Wirtz ◽  
E Briasoulis ◽  
G Hennig ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Mrna Expression ◽  
Early Breast Cancer ◽  
Oncology Group ◽  
Treatment Benefit ◽  
Poor Outcome ◽  
Group Trial ◽  
Molecular Predictor

scholarly journals Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study

2012 ◽  
Vol 23 (6) ◽  
pp. 1422-1427 ◽  
Author(s):  
A. Psyrri ◽  
K.T. Kalogeras ◽  
R. Kronenwett ◽  
R.M. Wirtz ◽  
A. Batistatou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Mrna Expression ◽  
Early Breast Cancer ◽  
Prognostic Significance ◽  
Oncology Group

scholarly journals Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study

PLoS ONE ◽  
2016 ◽  
Vol 11 (10) ◽  
pp. e0164013 ◽  
Author(s):  
Flora Stavridi ◽  
Konstantine T. Kalogeras ◽  
Kyriaki Pliarchopoulou ◽  
Ralph M. Wirtz ◽  
Zoi Alexopoulou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Clinical Treatment ◽  
Breast Cancer Patients ◽  
Oncology Group ◽  
Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document